Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,579.34
(
1.28%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
100.40
(
3.72%
)
Bitcoin
70,300.00
(
-0.85%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Rocky3 post# 175236

Sunday, 03/09/2014 4:41:01 PM

Sunday, March 09, 2014 4:41:01 PM

Post# of 257273

GILD—You may be right as to the p/e, but I would say that it is because the uncertainty about the HCV business a few years out.

It depends on whom you ask. In my opinion, GILD’s HCV business will plateau at a high level and stay there for several years, while GILD’s HIV business is at-risk for being halved or worse as soon as 2017.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today